You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 21, 2020

Atthachai Homhuan and Kittiya Nopparatrungroj Speak on New Normal in Pharma and Medical Devices

Subscribe to Updates

On May 21, Dr. Atthachai Homhuan, manager of regulatory affairs in Tilleke & Gibbins’ Bangkok office, and Kittiya Nopparatrungroj, consultant and licensed pharmacist, will join together to present a webinar cohosted by Tilleke & Gibbins and the Thai Listed Companies Association (TLCA).

Their session, entitled “New Normal in Pharma and Medical Devices: The Impact of COVID-19,” will dive into the responses to the COVID-19 outbreak by the Thai Food and Drug Administration and the Department of Internal Trade, and how government policy may affect the production and distribution of personal protective equipment, medical devices, and pharmaceutical products. Immediately following the webinar, Atthachai and Kittiya will respond to attendee questions through a brief Q&A session.

The webinar, which will be conducted in Thai language, will go live on Thursday, May 21, at 2:00 p.m. If you’re interested in attending, please register for the webinar by sending an email to [email protected].

RELATED PROFESSIONALS

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
Read More
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.
Read More
September 4, 2012
On September 21, 2012, Tilleke & Gibbins, together with the National Innovation Agency, will host a Thai-language seminar on “Medical Devices: Opportunities & Regulations.” The seminar with consist of three presentations, one of which will be conducted by Rarana Phanudulkitti, a consultant at Tilleke & Gibbins. With her expertise in regulatory affairs, Rarana will deal specifically with registering medical devices in Thailand, with an emphasis on best practices for companies in ensuring a smooth registration process.
Read More